Literature DB >> 33922606

The Multifaceted Mas-Related G Protein-Coupled Receptor Member X2 in Allergic Diseases and Beyond.

Paola Leonor Quan1, Marina Sabaté-Brescó1,2, Yanru Guo3,4, Margarita Martín3,4, Gabriel Gastaminza1,2.   

Abstract

Recent research on mast cell biology has turned its focus on MRGPRX2, a new member of the Mas-related G protein-coupled subfamily of receptors (Mrgprs), originally described in nociceptive neurons of the dorsal root ganglia. MRGPRX2, a member of this group, is present not only in neurons but also in mast cells (MCs), specifically, and potentially in other cells of the immune system, such as basophils and eosinophils. As emerging new functions for this receptor are studied, a variety of both natural and pharmacologic ligands are being uncovered, linked to the ability to induce receptor-mediated MC activation and degranulation. The diversity of these ligands, characterized in their human, mice, or rat homologues, seems to match that of the receptor's interactions. Natural ligands include host defense peptides, basic molecules, and key neuropeptides such as substance P and vasointestinal peptide (known for their role in the transmission of pain and itch) as well as eosinophil granule-derived proteins. Exogenous ligands include MC secretagogues such as compound 48/80 and mastoparan, a component of bee wasp venom, and several peptidergic drugs, among which are members of the quinolone family, neuromuscular blocking agents, morphine, and vancomycin. These discoveries shed light on its capacity as a multifaceted participant in naturally occurring responses within immunity and neural stimulus perception, as in responses at the center of immune pathology. In host defense, the mice Mrgprb2 has been proven to aid mast cells in the detection of peptidic molecules from bacteria and in the release of peptides with antimicrobial activities and other immune mediators. There are several potential actions described for it in tissue homeostasis and repair. In the realm of pathologic response, there is evidence to suggest that this receptor is also involved in chronic inflammation. Furthermore, MRGPRX2 has been linked to the pathophysiology of non-IgE-mediated immediate hypersensitivity drug reactions. Different studies have shown its possible role in other allergic diseases as well, such as asthma, atopic dermatitis, contact dermatitis, and chronic spontaneous urticaria. In this review, we sought to cover its function in physiologic processes and responses, as well as in allergic and nonallergic immune disease.

Entities:  

Keywords:  hypersensitivity; mas-related G protein-coupled receptor member X2 (MRGRPX2); mas-related G protein-coupled receptors; mast cells

Year:  2021        PMID: 33922606     DOI: 10.3390/ijms22094421

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  73 in total

1.  A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons.

Authors:  X Dong; S Han; M J Zylka; M I Simon; D J Anderson
Journal:  Cell       Date:  2001-09-07       Impact factor: 41.582

2.  Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria.

Authors:  Daisuke Fujisawa; Jun-Ichi Kashiwakura; Hirohito Kita; Yusuke Kikukawa; Yasushi Fujitani; Tomomi Sasaki-Sakamoto; Kazumichi Kuroda; Satoshi Nunomura; Koremasa Hayama; Tadashi Terui; Chisei Ra; Yoshimichi Okayama
Journal:  J Allergy Clin Immunol       Date:  2014-06-19       Impact factor: 10.793

3.  Molecular editing of cellular responses by the high-affinity receptor for IgE.

Authors:  Ryo Suzuki; Sarah Leach; Wenhua Liu; Evelyn Ralston; Jörg Scheffel; Weiguo Zhang; Clifford A Lowell; Juan Rivera
Journal:  Science       Date:  2014-02-06       Impact factor: 47.728

4.  Differential Regulation of Mas-Related G Protein-Coupled Receptor X2-Mediated Mast Cell Degranulation by Antimicrobial Host Defense Peptides and Porphyromonas gingivalis Lipopolysaccharide.

Authors:  Kshitij Gupta; Chizobam Idahosa; Saptarshi Roy; Donguk Lee; Hariharan Subramanian; Anuradha Dhingra; Kathleen Boesze-Battaglia; Jonathan Korostoff; Hydar Ali
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

5.  G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2.

Authors:  Sakeen W Kashem; Hariharan Subramanian; Sarah J Collington; Paola Magotti; John D Lambris; Hydar Ali
Journal:  Eur J Pharmacol       Date:  2011-07-03       Impact factor: 4.432

6.  The rat adenine receptor: pharmacological characterization and mutagenesis studies to investigate its putative ligand binding site.

Authors:  Melanie Knospe; Christa E Müller; Patrizia Rosa; Aliaa Abdelrahman; Ivar von Kügelgen; Dominik Thimm; Anke C Schiedel
Journal:  Purinergic Signal       Date:  2013-02-15       Impact factor: 3.765

7.  Allergic FcεRI- and pseudo-allergic MRGPRX2-triggered mast cell activation routes are independent and inversely regulated by SCF.

Authors:  M Babina; S Guhl; M Artuc; T Zuberbier
Journal:  Allergy       Date:  2017-09-20       Impact factor: 13.146

Review 8.  Mast cells signal their importance in health and disease.

Authors:  Ana Olivera; Michael A Beaven; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2018-02-15       Impact factor: 10.793

Review 9.  IgE and mast cells in allergic disease.

Authors:  Stephen J Galli; Mindy Tsai
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

10.  MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia.

Authors:  Arnau Navinés-Ferrer; Eva Serrano-Candelas; Alberto Lafuente; Rosa Muñoz-Cano; Margarita Martín; Gabriel Gastaminza
Journal:  Sci Rep       Date:  2018-08-02       Impact factor: 4.379

View more
  8 in total

Review 1.  Mast Cell Activation Syndrome in COVID-19 and Female Reproductive Function: Theoretical Background vs. Accumulating Clinical Evidence.

Authors:  Dariusz Szukiewicz; Piotr Wojdasiewicz; Mateusz Watroba; Grzegorz Szewczyk
Journal:  J Immunol Res       Date:  2022-06-22       Impact factor: 4.493

Review 2.  Mast Cells in the Mammalian Testis and Epididymis-Animal Models and Detection Methods.

Authors:  Marta Himelreich-Perić; Ana Katušić-Bojanac; Marko Hohšteter; Nino Sinčić; Vedrana Mužić-Radović; Davor Ježek
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

3.  Mast Cells: When the Best Defense Is an Attack?

Authors:  Margarita Martin
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

4.  β-arrestin-1 and β-arrestin-2 Restrain MRGPRX2-Triggered Degranulation and ERK1/2 Activation in Human Skin Mast Cells.

Authors:  Zhao Wang; Zhuoran Li; Gürkan Bal; Kristin Franke; Torsten Zuberbier; Magda Babina
Journal:  Front Allergy       Date:  2022-07-15

Review 5.  Targeting Mast Cells in Allergic Disease: Current Therapies and Drug Repurposing.

Authors:  Jason R Burchett; Jordan M Dailey; Sydney A Kee; Destiny T Pryor; Aditya Kotha; Roma A Kankaria; David B Straus; John J Ryan
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

Review 6.  Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors.

Authors:  Katerina Kalkusova; Sindija Smite; Elea Darras; Pavla Taborska; Dmitry Stakheev; Luca Vannucci; Jirina Bartunkova; Daniel Smrz
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

Review 7.  Anaphylaxis: Focus on Transcription Factor Activity.

Authors:  Yanru Guo; Elizabeth Proaño-Pérez; Rosa Muñoz-Cano; Margarita Martin
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

8.  MRGPRX2-Mediated Degranulation of Human Skin Mast Cells Requires the Operation of Gαi, Gαq, Ca++ Channels, ERK1/2 and PI3K-Interconnection between Early and Late Signaling.

Authors:  Zhao Wang; Kristin Franke; Gürkan Bal; Zhuoran Li; Torsten Zuberbier; Magda Babina
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.